Open AccessReactivation of Plasmodium infection during a treatment with infliximab: A case report
Author(s) -
Cecile Haeseleer,
Delphine Martiny,
Yves Van Laethem,
Brigitte Cantinieaux,
Charlotte Martin
Publication year - 2019
Publication title -
international journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.278
H-Index - 89
eISSN - 1878-3511
pISSN - 1201-9712
DOI - 10.1016/j.ijid.2019.11.016
Subject(s) - infliximab , malaria , plasmodium falciparum , medicine , immunology , virology , tumor necrosis factor alpha
We describe a symptomatic Plasmodium falciparum infection in a 29-year-old Guinean man receiving Infliximab for one year and without recent travel. The reactivation of submicroscopic malaria following the inhibition of TNF-alpha by infliximab is suspected.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom